Azar R F
Int Ophthalmol Clin. 1979 Fall;19(3):211-25. doi: 10.1097/00004397-197901930-00016.
Aphakia is a disabling condition. It must be corrected by spectacles, contact lenses, refractive keratoplasty, or insertion of a pseudophakos. In those patients who do not tolerate a contact lens or cataract spectacles, refractive keratoplasty or secondary implantation of an IOL should be considered. Keratophakia and hyperopic keratomileusis have not yet evolved to the point at which refractive keratoplasty can be considered a practical answer to aphakia. This leaves a significant population of aphakic patients who can be visually rehabilitated only be secondary implantation of an IOL. Despite the risks and hazards associated with any intraocular surgery, the benefits derived from successful correction of aphakia with secondary implantation fully justify this procedure. Secondary implantation is a proved, successful modality for the corretion of aphakia. The number of patients requiring secondary implantation is not great, but in patients in whom secondary implantation is indicated, both the patient and the physician will find the results most rewarding.
无晶状体是一种致残状况。必须通过眼镜、隐形眼镜、屈光性角膜成形术或植入人工晶状体来矫正。对于那些不能耐受隐形眼镜或白内障眼镜的患者，应考虑进行屈光性角膜成形术或二期人工晶状体植入。角膜屈光性晶状体置换术和远视性角膜磨镶术尚未发展到屈光性角膜成形术可被视为无晶状体的切实可行解决方案的程度。这就导致有相当一部分无晶状体患者只能通过二期人工晶状体植入来实现视力康复。尽管任何眼内手术都存在风险和危害，但通过二期植入成功矫正无晶状体所带来的益处完全证明了该手术的合理性。二期植入是矫正无晶状体的一种已被证实且成功的方式。需要二期植入的患者数量不多，但对于那些适合二期植入的患者，患者和医生都会发现结果非常令人满意。
